drugset / Trial / NCT05863832

Study to Assess the Safety & Efficacy of Oral Ciprodiazole Versus Currently Used Ciprofloxacin & Metronidazole

NCT05863832

Phase 4 Unknown 312 enrolled MinaPharm Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to assess the safety \& efficacy of Oral Ciprodiazole® versus currently used Ciprofloxacin Tablets \& Metronidazole tablets in pelvi-abdominal infections and following IV antibiotics in post-operative period, for pelvi-abdominal surgeries or acute conditions

Timeline

Start
2021-08-17
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 500 mg Oral
Comparator Metronidazole Small molecule 500 mg Oral

Indications

No indication recorded.